Our dedicated DCT Management Platform can assist you in conducting entirely virtual, hybrid, or decentralized clinical trials, providing research organizations with the necessary flexibility and integration to efficiently oversee all facets of their clinical trial without sacrificing data integrity or compliance.
With our Decentralized Clinical Trial Management Platform, clinical operations, data management, and regulatory teams are provided with a comprehensive system to manage all aspects of remote and hybrid clinical trials. Right from remote consent to collecting data at home, managing virtual visits, providing patient direct supplies, integrating wearables, and decentralized site monitoring, all operational needs of today’s decentralized trial have been covered in our platform.
Give every DCT operations team the integrated platform they need to run flexible, patient-centric trials that maintain the scientific rigor and regulatory compliance of traditional research.
See Platform DocumentationRemote consent, home-based data collection, telemedicine visits, direct-to-patient supply, and decentralized monitoring, all managed within one platform. Complete operational coverage that eliminates the tool fragmentation that undermines DCT efficiency.
The system features modules that enable the use of electronic consent, patient data collection remotely via the use of mobile/web application for patients, scheduling and managing of telemedicine visits, integration of patient data from wearables and remote devices, logistics of investigational products to patients, and risk-based remote site monitoring. All modules are built on the same data platform, which gives visibility of the whole process.
Explore DCT Operations ModulesPatients engaged from home, sites supported remotely, sponsors informed in real time. Connectivity that makes geographic distance irrelevant to trial quality and operational oversight.
The use of secure applications for patients on both mobile and web platforms will ensure that trial participants remain engaged, educated, and compliant with all study requirements from wherever they may be, whereas the applications designed for sites will enable investigators working remotely to have access to the same functionalities as they would in conventional trial settings. Sponsors and CROs can monitor their trials in real-time through dedicated dashboards.
View Patient and Site Connectivity FeaturesRemote does not mean less rigorous. Every DCT function is designed to meet FDA, EMA, and ICH regulatory expectations for decentralized and hybrid trial conduct.
The tool features workflows that are in accordance with guidelines for remote informed consent, data quality of assessments done at home, direct to patient supply accountability, and decentralized monitoring documentation, thereby making sure that every single element of your DCT adheres to the latest FDA, EMA, and ICH guidelines regarding decentralized trials.
Learn About DCT Regulatory Compliance